Secondary metabolites: The focus of biodiscovery and perhaps the key to unlocking new depths in taxonomy

Ernest Lacey and Shaun Tennant

Microbiology in Australia 2003, 24, 34-35.

Publication Date: 2003

https://doi.org/10.1071/MA03334

Abstract:

Drug discovery is driven, either directly or indirectly, by biodiversity. Over half of the new chemical entities approved by regulatory authorities over the past decade are from natural sources. Australia’s natural resources contain unique, diverse and geographically distinct pools of biodiversity that have been only superficially utilised.

Contact Us

Business Development

Microbial Diversity

Metabolic & Chemical Diversity

Technology

Publications

BioAustalis

Stay in the loop

Recent publications